UTHSC study aims to develop a new way to treat ischemic stroke

A study at the University of Tennessee Health Science Center aims to develop a new way to treat ischemic stroke, a leading cause of death in adults worldwide.

CMS’ Medicare negotiation list is coming next week. Here’s what to expect

The clock is ticking as pharma companies wait to see what 10 Medicare Part D drugs will be up for the first round of price

August 25, 2023

Neuro startup stock craters after PhIII study marred with ‘significant deviation’ from trial protocol

A Nevada startup researching an Alzheimer’s drug saw its stock crater Wednesday morning after it reported Phase III results that included data integrity issues at

November 30, 2023

FDA pledges to take next steps on advisory committee changes

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.